Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence

Marteau, Theresa M; Munafò, Marcus R; Aveyard, Paul; Hill, Chloe; Whitwell, Sophia; Willis, Thomas A; Crockett, Rachel A; Hollands, Gareth J; Johnstone, Elaine C; Wright, Alison J; Prevost, A Toby; Armstrong, David; Sutton, Stephen; Kinmonth, Ann Louise
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p680
Academic Journal
Background: The behavioural impact of pharmacogenomics is untested; informing smokers of genetic test results for responsiveness to smoking cessation medication may increase adherence to this medication. The objective of this trial is to estimate the impact upon adherence to nicotine replacement therapy (NRT) of informing smokers that their oral dose of NRT has been tailored to a DNA analysis. Hypotheses to be tested are as follows: I Adherence to NRT is greater among smokers informed that their oral dose of NRT is tailored to an analysis of DNA (genotype), compared to one tailored to nicotine dependence questionnaire score (phenotype). II Amongst smokers who fail to quit at six months, motivation to make another quit attempt is lower when informed that their oral dose of NRT was tailored to genotype rather than phenotype. Methods/Design: An open label, parallel groups randomised trial in which 630 adult smokers (smoking 10 or more cigarettes daily) using National Health Service (NHS) stop smoking services in primary care are randomly allocated to one of two groups: i. NRT oral dose tailored by DNA analysis (OPRM1 gene) (genotype), or ii. NRT oral dose tailored by nicotine dependence questionnaire score (phenotype) The primary outcome is proportion of prescribed NRT consumed in the first 28 days following an initial quit attempt, with the secondary outcome being motivation to make another quit attempt, amongst smokers not abstinent at six months. Other outcomes include adherence to NRT in the first seven days and biochemically validated smoking abstinence at six months. The primary outcome will be collected on 630 smokers allowing sufficient power to detect a 7.5% difference in mean proportion of NRT consumed using a two-tailed test at the 5% level of significance between groups. The proportion of all NRT consumed in the first four weeks of quitting will be compared between arms using an independent samples t-test and by estimating the 95% confidence interval for observed between-arm difference in mean NRT consumption (Hypothesis I). Motivation to make another quit attempt will be compared between arms in those failing to quit by six months (Hypothesis II). Discussion: This is the first clinical trial evaluating the behavioural impact on adherence of prescribing medication using genetic rather than phenotypic information. Specific issues regarding the choice of design for trials of interventions of this kind are discussed. Trial details: Funder: Medical Research Council (MRC)


Related Articles

  • Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Swan, G E; Javitz, H S; Jack, L M; Wessel, J; Michel, M; Hinds, D A; Stokowksi, R P; McClure, J B; Catz, S L; Richards, J; Zbikowski, S M; Deprey, M; McAfee, T; Conti, D V; Bergen, A W // Pharmacogenomics Journal;Aug2012, Vol. 12 Issue 4, p349 

    This study evaluated association between common and rare sequence variants in 10 nicotinic acetylcholine receptor subunit genes and the severity of nausea 21 days after initiating the standard, Food and Drug Administration-approved varenicline regimen for smoking cessation. A total of 397...

  • Extended-duration transdermal nicotine therapy was more effective than standard-duration therapy for smoking cessation. Lancaster, Tim; Stead, Lindsay // ACP Journal Club;4/20/2010, Vol. 152 Issue 4, p7 

    The article presents information on a study undertaken to find if extended-duration transdermal nicotine therapy is more effective than standard-duration therapy for smoking cessation. 573 adults participated in the randomized controlled trial. The study found that extended-duration transdermal...

  • Adherence to treatment for tobacco dependence: Association with smoking abstinence and predictors of adherence. Hays, J. Taylor; Leischow, Scott J.; Lawrence, David; Lee, Theodore C. // Nicotine & Tobacco Research;Jun2010, Vol. 12 Issue 6, p574 

    Introduction:: Detailed analysis of adherence to tobacco cessation medications and predictors of adherence is sparse in published literature. In this analysis, we assessed adherence to tobacco dependence treatment, association of adherence with abstinence, and predictors of adherence.

  • Adherence to nicotine replacement therapy among pregnant smokers. Fish, Laura J.; Peterson, Bercedis L.; Brouwer Namenek, Rebecca J.; Lyna, Pauline; Oncken, Cheryl A.; Swamy, Geeta K.; Myers, Evan R.; Pletsch, Pamela K.; Pollak, Kathryn I. // Nicotine & Tobacco Research;May2009, Vol. 11 Issue 5, p514 

    Introduction:: This secondary analysis examined the association between adherence to nicotine replacement therapy (NRT) and smoking cessation among pregnant smokers enrolled in Baby Steps, an open-label randomized controlled trial testing cognitive-behavioral therapy (CBT) versus CBT plus NRT.

  • Randomized controlled trial of mailed Nicotine Replacement Therapy to Canadian smokers: study protocol.  // BMC Public Health;2011, Vol. 11 Issue 1, p741 

    The article presents the findings of a randomized controlled trial conducted on examining whether smoking cessation programs that involve mailed distribution of free Nicotine Replacement Therapy (NRT) work are effective in Canada. It discusses the methods used in conducting the trial. It reports...

  • Effectiveness of smoking-cessation interventions for urban hospital patients: study protocol for a randomized controlled trial. Grossman, Ellie; Shelley, Donna; Braithwaite, R Scott; Lobach, Iryna; Goffin, Ana; Rogers, Erin; Sheman, Scott // Trials;2012, Vol. 13 Issue 1, p126 

    Background: Hospitalization may be a particularly important time to promote smoking cessation, especially in the immediate post-discharge period. However, there are few studies to date that shed light on the most effective or cost-effective methods to provide post-discharge cessation treatment,...

  • Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion. Patterson, F.; Schnoll, R. A.; Wileyto, E. P.; Pinto, A.; Epstein, L. H.; Shields, P. G.; Hawk, L. W.; Tyndale, R. F.; Benowitz, N.; Lerman, C. // Clinical Pharmacology & Therapeutics;Sep2008, Vol. 84 Issue 3, p320 

    The article reports on the randomized placebo-controlled trial of bupropion as a personalized therapy for smoking cessation. This study examined a group of smokers that were tested for pretreatment nicotine metabolism rate (NMR) to know whether a pretreatment of NMR could stop them from smoking...

  • E-Cigarettes--Prevention, Pulmonary Health, and Addiction. Nowak, Dennis; Jörres, Rudolf A.; Rüther, Tobias // Deutsches Aerzteblatt International;5/16/2014, Vol. 111 Issue 20, p349 

    Background: E-cigarettes are coming into wider use. They are advertised as an aid to smoking cessation, but there is concern that they may also serve as a gateway drug for cigarette smoking. Methods: The authors systematically searched the PubMed database for relevant publications on the...

  • Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP). Essex, Holly N.; Parrott, Steve; Qi Wu; Jinshuo Li; Cooper, Sue; Coleman, Tim // Nicotine & Tobacco Research;Jun2015, Vol. 17 Issue 6, p636 

    Introduction: Smoking during pregnancy is the most important, preventable cause of adverse pregnancy outcomes including miscarriage, premature birth, and low birth weight with huge financial costs to the National Health Service. However, there are very few published economic evaluations of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics